Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Moertel

Showing results (181-190 of 251) with videos related to

Pageof 26
Sort By:
Cancer Treatment Reports|May 1, 1987
Phase I study of two schedules of teroxironeJ Rubin, J S Kovach, M M Ames, et al.
American Journal of Clinical Oncology|April 1, 1987
Alpha-fetoprotein associated with islet cell tumorsJ J Lokich, O P Ganda, C J O'Hara, et al.
Cancer|March 1, 1976
A phase I study of cytembenaS Frytak, C G Moertel, A J Schutt, et al.
Cancer Research|November 1, 1979
Toxicity and pharmacokinetics of a pyrrolizidine alkaloid, indicine N-oxide, in humansJ S Kovach, M M Ames, G Powis, et al.
Journal of the National Cancer Institute|March 1, 1974
Carcinoembryonic antigen and alpha-fetoprotein in the diagnosis of gastric and colonic cancer: a comparative clinical evaluationM Ravry, K R McIntire, C G Moertel, et al.
Journal of Surgical Oncology|July 1, 1982
Human colorectal carcinoma: patterns of sensitivity to chemotherapeutic agents in the human tumor stem cell assayM V Agrez, J S Kovach, R W Beart, et al.
Cancer Chemotherapy Reports|September 1, 1973
Phase I study of chromomycin A (NSC-58514)J S Kovach, C G Moertel, D L Ahmann, et al.
Oncology|January 1, 1974
A controlled evaluation of 5-fluorouracil utilizing a single injection techniqueD L Ahmann, C G Moertel, H F Bisel, et al.
Journal of the National Cancer Institute|December 20, 1989
Comparison of the pharmacokinetics of octreotide injected at two subcutaneous sitesS R Patel, L K Kvols, D A Peterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinomaC G Moertel, D S Childs, J R O'Fallon, et al.
Pageof 26

Showing results (181-190 of 251) with videos related to

Sort By:
Pageof 26
Cancer Treatment Reports|May 1, 1987
Phase I study of two schedules of teroxironeJ Rubin, J S Kovach, M M Ames, et al.
American Journal of Clinical Oncology|April 1, 1987
Alpha-fetoprotein associated with islet cell tumorsJ J Lokich, O P Ganda, C J O'Hara, et al.
Cancer|March 1, 1976
A phase I study of cytembenaS Frytak, C G Moertel, A J Schutt, et al.
Cancer Research|November 1, 1979
Toxicity and pharmacokinetics of a pyrrolizidine alkaloid, indicine N-oxide, in humansJ S Kovach, M M Ames, G Powis, et al.
Journal of the National Cancer Institute|March 1, 1974
Carcinoembryonic antigen and alpha-fetoprotein in the diagnosis of gastric and colonic cancer: a comparative clinical evaluationM Ravry, K R McIntire, C G Moertel, et al.
Journal of Surgical Oncology|July 1, 1982
Human colorectal carcinoma: patterns of sensitivity to chemotherapeutic agents in the human tumor stem cell assayM V Agrez, J S Kovach, R W Beart, et al.
Cancer Chemotherapy Reports|September 1, 1973
Phase I study of chromomycin A (NSC-58514)J S Kovach, C G Moertel, D L Ahmann, et al.
Oncology|January 1, 1974
A controlled evaluation of 5-fluorouracil utilizing a single injection techniqueD L Ahmann, C G Moertel, H F Bisel, et al.
Journal of the National Cancer Institute|December 20, 1989
Comparison of the pharmacokinetics of octreotide injected at two subcutaneous sitesS R Patel, L K Kvols, D A Peterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinomaC G Moertel, D S Childs, J R O'Fallon, et al.
Pageof 26